Wells Fargo Maintains Overweight on Zimmer Biomet Holdings, Raises Price Target to $170

Wells Fargo analyst Larry Biegelsen maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Overweight and raises the price target from $165 to $170.

Benzinga · 01/10/2020 13:56

Wells Fargo analyst Larry Biegelsen maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Overweight and raises the price target from $165 to $170.